

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.19017585 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.19017585 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.71351591 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.71351591 |
| 5 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.56901565 |
| 6 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.56901565 |
| 7 | NADH dehydrogenase complex assembly (GO:0010257) | 4.56901565 |
| 8 | protein complex biogenesis (GO:0070271) | 4.51422564 |
| 9 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.48498833 |
| 10 | chaperone-mediated protein transport (GO:0072321) | 4.41372184 |
| 11 | sodium-independent organic anion transport (GO:0043252) | 4.34449096 |
| 12 | response to misfolded protein (GO:0051788) | 4.08186962 |
| 13 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.05641600 |
| 14 | regulation of autophagic vacuole assembly (GO:2000785) | 4.03903509 |
| 15 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.00552662 |
| 16 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.89841450 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 3.89759823 |
| 18 | ubiquinone biosynthetic process (GO:0006744) | 3.85300108 |
| 19 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.77824232 |
| 20 | positive regulation of mitochondrial fission (GO:0090141) | 3.73447450 |
| 21 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.71562293 |
| 22 | nucleobase catabolic process (GO:0046113) | 3.69637957 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 3.61892871 |
| 24 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.61283111 |
| 25 | ubiquinone metabolic process (GO:0006743) | 3.60745509 |
| 26 | mannosylation (GO:0097502) | 3.60410035 |
| 27 | peptidyl-histidine modification (GO:0018202) | 3.58073303 |
| 28 | bile acid biosynthetic process (GO:0006699) | 3.57684131 |
| 29 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.57077757 |
| 30 | activated T cell proliferation (GO:0050798) | 3.55271863 |
| 31 | valine metabolic process (GO:0006573) | 3.47732329 |
| 32 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.47070462 |
| 33 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.47070462 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.44616043 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.44370885 |
| 36 | response to pheromone (GO:0019236) | 3.39910562 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 3.38263694 |
| 38 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.37978923 |
| 39 | ATP synthesis coupled proton transport (GO:0015986) | 3.37978923 |
| 40 | base-excision repair, AP site formation (GO:0006285) | 3.37464504 |
| 41 | regulation of vacuole organization (GO:0044088) | 3.37067465 |
| 42 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.36777796 |
| 43 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.32039279 |
| 44 | amino acid salvage (GO:0043102) | 3.31059866 |
| 45 | L-methionine salvage (GO:0071267) | 3.31059866 |
| 46 | L-methionine biosynthetic process (GO:0071265) | 3.31059866 |
| 47 | coenzyme catabolic process (GO:0009109) | 3.28527210 |
| 48 | synaptic vesicle maturation (GO:0016188) | 3.17593477 |
| 49 | respiratory electron transport chain (GO:0022904) | 3.17444113 |
| 50 | electron transport chain (GO:0022900) | 3.17410488 |
| 51 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.16673897 |
| 52 | mitochondrion degradation (GO:0000422) | 3.13726184 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.11870990 |
| 54 | glutamate metabolic process (GO:0006536) | 3.11547023 |
| 55 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.10754224 |
| 56 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.10659566 |
| 57 | fatty acid elongation (GO:0030497) | 3.10644822 |
| 58 | quinone biosynthetic process (GO:1901663) | 3.07990793 |
| 59 | behavioral response to nicotine (GO:0035095) | 3.05599389 |
| 60 | peroxisome fission (GO:0016559) | 3.02606437 |
| 61 | bile acid metabolic process (GO:0008206) | 3.01216041 |
| 62 | negative regulation of telomere maintenance (GO:0032205) | 3.00106792 |
| 63 | regulation of mitochondrial translation (GO:0070129) | 2.99796191 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 2.98159191 |
| 65 | kynurenine metabolic process (GO:0070189) | 2.97155423 |
| 66 | glutamate secretion (GO:0014047) | 2.96307823 |
| 67 | mitochondrion morphogenesis (GO:0070584) | 2.95856093 |
| 68 | intracellular protein transmembrane import (GO:0044743) | 2.95281919 |
| 69 | protein targeting to mitochondrion (GO:0006626) | 2.93263482 |
| 70 | vocalization behavior (GO:0071625) | 2.93154735 |
| 71 | ketone body metabolic process (GO:1902224) | 2.91486162 |
| 72 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.89979015 |
| 73 | regulation of cilium movement (GO:0003352) | 2.89884260 |
| 74 | protein polyglutamylation (GO:0018095) | 2.89317928 |
| 75 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.88705593 |
| 76 | cytochrome complex assembly (GO:0017004) | 2.87702234 |
| 77 | respiratory chain complex IV assembly (GO:0008535) | 2.87639608 |
| 78 | sulfur amino acid catabolic process (GO:0000098) | 2.84097430 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83967683 |
| 80 | tyrosine metabolic process (GO:0006570) | 2.83961954 |
| 81 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.83839520 |
| 82 | alpha-amino acid catabolic process (GO:1901606) | 2.82776962 |
| 83 | establishment of protein localization to mitochondrion (GO:0072655) | 2.80338103 |
| 84 | dicarboxylic acid catabolic process (GO:0043649) | 2.80256452 |
| 85 | DNA deamination (GO:0045006) | 2.79960610 |
| 86 | indolalkylamine catabolic process (GO:0046218) | 2.77701750 |
| 87 | tryptophan catabolic process (GO:0006569) | 2.77701750 |
| 88 | indole-containing compound catabolic process (GO:0042436) | 2.77701750 |
| 89 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.75814180 |
| 90 | lysine catabolic process (GO:0006554) | 2.75521991 |
| 91 | lysine metabolic process (GO:0006553) | 2.75521991 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 2.75303848 |
| 93 | urea cycle (GO:0000050) | 2.74923006 |
| 94 | urea metabolic process (GO:0019627) | 2.74923006 |
| 95 | platelet dense granule organization (GO:0060155) | 2.74089706 |
| 96 | aspartate family amino acid catabolic process (GO:0009068) | 2.73962597 |
| 97 | locomotory exploration behavior (GO:0035641) | 2.70360011 |
| 98 | hydrogen ion transmembrane transport (GO:1902600) | 2.70170268 |
| 99 | protein localization to mitochondrion (GO:0070585) | 2.69970750 |
| 100 | inner mitochondrial membrane organization (GO:0007007) | 2.69263780 |
| 101 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.68941090 |
| 102 | neurotransmitter secretion (GO:0007269) | 2.68779761 |
| 103 | cofactor catabolic process (GO:0051187) | 2.68108976 |
| 104 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.67966191 |
| 105 | cellular amino acid catabolic process (GO:0009063) | 2.67690524 |
| 106 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.67463714 |
| 107 | dendrite morphogenesis (GO:0048813) | 2.67216056 |
| 108 | tryptophan metabolic process (GO:0006568) | 2.66904905 |
| 109 | regulation of fibrinolysis (GO:0051917) | 2.66726343 |
| 110 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.65100005 |
| 111 | regulation of synapse structural plasticity (GO:0051823) | 2.63796230 |
| 112 | complement activation, alternative pathway (GO:0006957) | 2.63356904 |
| 113 | negative regulation of lipase activity (GO:0060192) | 2.62626073 |
| 114 | neuron cell-cell adhesion (GO:0007158) | 2.61790141 |
| 115 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.61762145 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 2.61653114 |
| 117 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.61237806 |
| 118 | aromatic amino acid family metabolic process (GO:0009072) | 2.61188187 |
| 119 | synaptic vesicle exocytosis (GO:0016079) | 2.61116556 |
| 120 | ADP metabolic process (GO:0046031) | 2.60954845 |
| 121 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.60823293 |
| 122 | cysteine metabolic process (GO:0006534) | 2.59418464 |
| 123 | succinate metabolic process (GO:0006105) | 2.58923149 |
| 124 | GTP biosynthetic process (GO:0006183) | 2.57837048 |
| 125 | positive regulation of protein homooligomerization (GO:0032464) | 2.57001444 |
| 126 | high-density lipoprotein particle remodeling (GO:0034375) | 2.56773031 |
| 127 | positive regulation of icosanoid secretion (GO:0032305) | 2.56520958 |
| 128 | C-terminal protein lipidation (GO:0006501) | 2.56517152 |
| 129 | very long-chain fatty acid metabolic process (GO:0000038) | 2.56082344 |
| 130 | regulation of protein activation cascade (GO:2000257) | 2.53811179 |
| 131 | nitrogen cycle metabolic process (GO:0071941) | 2.53766965 |
| 132 | positive regulation of catecholamine secretion (GO:0033605) | 2.53207593 |
| 133 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52668926 |
| 134 | short-chain fatty acid metabolic process (GO:0046459) | 2.52268897 |
| 135 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.52146968 |
| 136 | tricarboxylic acid metabolic process (GO:0072350) | 2.52114614 |
| 137 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.52004292 |
| 138 | synaptic transmission, glutamatergic (GO:0035249) | 2.51963200 |
| 139 | proton transport (GO:0015992) | 2.51888887 |
| 140 | central nervous system myelination (GO:0022010) | 2.51768454 |
| 141 | axon ensheathment in central nervous system (GO:0032291) | 2.51768454 |
| 142 | intracellular protein transmembrane transport (GO:0065002) | 2.51352127 |
| 143 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.50763178 |
| 144 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.50763178 |
| 145 | layer formation in cerebral cortex (GO:0021819) | 2.49761095 |
| 146 | protein insertion into membrane (GO:0051205) | 2.49521279 |
| 147 | hydrogen transport (GO:0006818) | 2.49466019 |
| 148 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48588485 |
| 149 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.48042271 |
| 150 | regulation of mitochondrial fission (GO:0090140) | 2.47336915 |
| 151 | cellular response to glucagon stimulus (GO:0071377) | 2.47311471 |
| 152 | regulation of microtubule-based movement (GO:0060632) | 2.46128886 |
| 153 | cellular potassium ion homeostasis (GO:0030007) | 2.46028319 |
| 154 | regulation of synaptic vesicle transport (GO:1902803) | 2.45240115 |
| 155 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.44648878 |
| 156 | regulation of oxidative phosphorylation (GO:0002082) | 2.44611461 |
| 157 | triglyceride homeostasis (GO:0070328) | 2.44215232 |
| 158 | acylglycerol homeostasis (GO:0055090) | 2.44215232 |
| 159 | protein import into peroxisome matrix (GO:0016558) | 2.43684647 |
| 160 | 2-oxoglutarate metabolic process (GO:0006103) | 2.43473408 |
| 161 | deoxyribonucleotide catabolic process (GO:0009264) | 2.42531794 |
| 162 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.42514291 |
| 163 | neuronal ion channel clustering (GO:0045161) | 2.42462429 |
| 164 | branched-chain amino acid metabolic process (GO:0009081) | 2.42023943 |
| 165 | acetyl-CoA metabolic process (GO:0006084) | 2.41308590 |
| 166 | sperm motility (GO:0030317) | 2.41168653 |
| 167 | glial cell proliferation (GO:0014009) | 2.40519149 |
| 168 | epithelial cilium movement (GO:0003351) | 2.40380241 |
| 169 | negative regulation of necroptotic process (GO:0060546) | 2.38914386 |
| 170 | viral protein processing (GO:0019082) | 2.38523278 |
| 171 | tRNA processing (GO:0008033) | 2.37863223 |
| 172 | acyl-CoA biosynthetic process (GO:0071616) | 2.37380259 |
| 173 | thioester biosynthetic process (GO:0035384) | 2.37380259 |
| 174 | branched-chain amino acid catabolic process (GO:0009083) | 2.36852521 |
| 175 | transferrin transport (GO:0033572) | 2.36653624 |
| 176 | regulation of complement activation (GO:0030449) | 2.35904299 |
| 177 | nonmotile primary cilium assembly (GO:0035058) | 2.35681036 |
| 178 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.34673383 |
| 179 | xenobiotic catabolic process (GO:0042178) | 2.34299428 |
| 180 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.34105832 |
| 181 | negative regulation of microtubule polymerization (GO:0031115) | 2.33964048 |
| 182 | axoneme assembly (GO:0035082) | 2.31814329 |
| 183 | ethanol oxidation (GO:0006069) | 2.31711037 |
| 184 | positive regulation of TOR signaling (GO:0032008) | 2.31176639 |
| 185 | organic acid catabolic process (GO:0016054) | 2.30872565 |
| 186 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.28945524 |
| 187 | C-terminal protein amino acid modification (GO:0018410) | 2.28816374 |
| 188 | trivalent inorganic cation transport (GO:0072512) | 2.28758031 |
| 189 | ferric iron transport (GO:0015682) | 2.28758031 |
| 190 | dendritic spine morphogenesis (GO:0060997) | 2.27170699 |
| 191 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.26638363 |
| 192 | termination of RNA polymerase III transcription (GO:0006386) | 2.26638363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.34025719 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.30246435 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.25804060 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.80975098 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.64355156 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.13558000 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00999461 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.61873655 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.57937700 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.55520639 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.54470688 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.50799148 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43086554 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.38705863 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36074254 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.30747834 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.27487879 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.24845708 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.24741723 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.24273034 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.23100973 |
| 22 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.21705760 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16863667 |
| 24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.15690726 |
| 25 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.12866361 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.12072834 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10708594 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09765673 |
| 29 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08825424 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.08749076 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.08669026 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04683939 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.04450001 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.02292799 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01318493 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01318493 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97659312 |
| 38 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.89768299 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86254881 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86195816 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85801564 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.85460600 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.84916472 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84383872 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81253863 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.75397862 |
| 47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69589831 |
| 48 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.68946373 |
| 49 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68038323 |
| 50 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67432675 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.64981863 |
| 52 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61073157 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61058122 |
| 54 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.60612387 |
| 55 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59755116 |
| 56 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.57613082 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56249711 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56053432 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52425263 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51809085 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50774769 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50042428 |
| 63 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.46398092 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45930670 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45627955 |
| 66 | ERA_21632823_ChIP-Seq_H3396_Human | 1.43868277 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42240896 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42209314 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.41881703 |
| 70 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.36739268 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34735558 |
| 72 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.34415929 |
| 73 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.34395828 |
| 74 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.33410069 |
| 75 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.33244560 |
| 76 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.32681798 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32609964 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32378010 |
| 79 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.31555543 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31297248 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30786953 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29270641 |
| 83 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.28905492 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28398501 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28156703 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23053127 |
| 87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22979570 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21980131 |
| 89 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.20379780 |
| 90 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19842952 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19360512 |
| 92 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.18888176 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18682306 |
| 94 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.18557088 |
| 95 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17919744 |
| 96 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.16271783 |
| 97 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14961164 |
| 98 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.12409545 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11070103 |
| 100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11051423 |
| 101 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.10982384 |
| 102 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10315670 |
| 103 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10097110 |
| 104 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09821242 |
| 105 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.09368898 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08650111 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08375476 |
| 108 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07352572 |
| 109 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06814090 |
| 110 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05886197 |
| 111 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.05123089 |
| 112 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04995723 |
| 113 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04454825 |
| 114 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03756537 |
| 115 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02554417 |
| 116 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01620658 |
| 117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00173075 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99523710 |
| 119 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99488761 |
| 120 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99045365 |
| 121 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98525519 |
| 122 | AR_19668381_ChIP-Seq_PC3_Human | 0.98419931 |
| 123 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98021322 |
| 124 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.97954280 |
| 125 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97363021 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96902197 |
| 127 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94910098 |
| 128 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94849437 |
| 129 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94361249 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94022517 |
| 131 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94021269 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93703995 |
| 133 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93634347 |
| 134 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93105927 |
| 135 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92396609 |
| 136 | P300_27268052_Chip-Seq_Bcells_Human | 0.92012883 |
| 137 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91169200 |
| 138 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90438126 |
| 139 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90370712 |
| 140 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90088987 |
| 141 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90010778 |
| 142 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88576495 |
| 143 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88111040 |
| 144 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87969341 |
| 145 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86888434 |
| 146 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86159162 |
| 147 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85991713 |
| 148 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85531075 |
| 149 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.85143227 |
| 150 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85011304 |
| 151 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84688636 |
| 152 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.84568962 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82397028 |
| 154 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81998394 |
| 155 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81451037 |
| 156 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81426047 |
| 157 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.81169681 |
| 158 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.80859753 |
| 159 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80590678 |
| 160 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80578510 |
| 161 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79870481 |
| 162 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79806943 |
| 163 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78543266 |
| 164 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78451220 |
| 165 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78183445 |
| 166 | AR_25329375_ChIP-Seq_VCAP_Human | 0.77918762 |
| 167 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.77224447 |
| 168 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77043419 |
| 169 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76757991 |
| 170 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76635336 |
| 171 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76108935 |
| 172 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.74159317 |
| 173 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73458713 |
| 174 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71289139 |
| 175 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.71119557 |
| 176 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70238880 |
| 177 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.70047026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.50168444 |
| 2 | MP0005360_urolithiasis | 3.45304633 |
| 3 | MP0005365_abnormal_bile_salt | 3.43290760 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.40376928 |
| 5 | MP0002102_abnormal_ear_morphology | 3.12836302 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.04124530 |
| 7 | MP0004270_analgesia | 2.97128532 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.69253481 |
| 9 | MP0002876_abnormal_thyroid_physiology | 2.51896378 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.33860142 |
| 11 | MP0002064_seizures | 2.32382038 |
| 12 | MP0003329_amyloid_beta_deposits | 2.18515127 |
| 13 | MP0009745_abnormal_behavioral_response | 2.11268080 |
| 14 | MP0003880_abnormal_central_pattern | 2.08868202 |
| 15 | MP0002272_abnormal_nervous_system | 2.05922910 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.01119103 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.98073661 |
| 18 | MP0003868_abnormal_feces_composition | 1.96814315 |
| 19 | MP0003252_abnormal_bile_duct | 1.96596157 |
| 20 | MP0009046_muscle_twitch | 1.94155059 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.89972764 |
| 22 | MP0001905_abnormal_dopamine_level | 1.88988948 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.88295313 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.86893387 |
| 25 | MP0002822_catalepsy | 1.84561098 |
| 26 | MP0003136_yellow_coat_color | 1.82295600 |
| 27 | MP0002063_abnormal_learning/memory/cond | 1.78744852 |
| 28 | MP0001486_abnormal_startle_reflex | 1.78195641 |
| 29 | MP0009840_abnormal_foam_cell | 1.76691105 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.74890894 |
| 31 | MP0003195_calcinosis | 1.73041208 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.71957411 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.70191208 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.69782690 |
| 35 | MP0000778_abnormal_nervous_system | 1.66199133 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.64221800 |
| 37 | MP0002736_abnormal_nociception_after | 1.56294702 |
| 38 | MP0001188_hyperpigmentation | 1.56069883 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.55446479 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.55161018 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.53299263 |
| 42 | MP0002163_abnormal_gland_morphology | 1.51236810 |
| 43 | MP0005083_abnormal_biliary_tract | 1.50990496 |
| 44 | MP0005253_abnormal_eye_physiology | 1.50186743 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.49192045 |
| 46 | MP0002184_abnormal_innervation | 1.47721561 |
| 47 | MP0005332_abnormal_amino_acid | 1.47277462 |
| 48 | MP0004133_heterotaxia | 1.46675747 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.46109762 |
| 50 | MP0000920_abnormal_myelination | 1.45701657 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.43610533 |
| 52 | MP0003787_abnormal_imprinting | 1.42541519 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.39656198 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.38899897 |
| 55 | MP0005410_abnormal_fertilization | 1.38728737 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.38510609 |
| 57 | MP0001764_abnormal_homeostasis | 1.35396199 |
| 58 | MP0008872_abnormal_physiological_respon | 1.34840295 |
| 59 | MP0005423_abnormal_somatic_nervous | 1.34641649 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.34567176 |
| 61 | MP0000955_abnormal_spinal_cord | 1.34468335 |
| 62 | MP0000538_abnormal_urinary_bladder | 1.33940156 |
| 63 | MP0004043_abnormal_pH_regulation | 1.32767830 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.32649350 |
| 65 | MP0008569_lethality_at_weaning | 1.30996669 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.30799641 |
| 67 | MP0001756_abnormal_urination | 1.29894546 |
| 68 | MP0004885_abnormal_endolymph | 1.28166138 |
| 69 | MP0003011_delayed_dark_adaptation | 1.27621604 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.26035483 |
| 71 | MP0001984_abnormal_olfaction | 1.24819471 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.24667692 |
| 73 | MP0004924_abnormal_behavior | 1.24667692 |
| 74 | MP0003315_abnormal_perineum_morphology | 1.20198296 |
| 75 | MP0003690_abnormal_glial_cell | 1.20174279 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19037107 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.18339167 |
| 78 | MP0002234_abnormal_pharynx_morphology | 1.18098933 |
| 79 | MP0010386_abnormal_urinary_bladder | 1.15515467 |
| 80 | MP0005394_taste/olfaction_phenotype | 1.13843084 |
| 81 | MP0005499_abnormal_olfactory_system | 1.13843084 |
| 82 | MP0006276_abnormal_autonomic_nervous | 1.13438419 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 1.12846207 |
| 84 | MP0005535_abnormal_body_temperature | 1.12778416 |
| 85 | MP0002653_abnormal_ependyma_morphology | 1.12632159 |
| 86 | MP0002882_abnormal_neuron_morphology | 1.12351480 |
| 87 | MP0003879_abnormal_hair_cell | 1.12178883 |
| 88 | MP0003186_abnormal_redox_activity | 1.12040011 |
| 89 | MP0004142_abnormal_muscle_tone | 1.11413951 |
| 90 | MP0001970_abnormal_pain_threshold | 1.10292560 |
| 91 | MP0000604_amyloidosis | 1.08928371 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 1.06266958 |
| 93 | MP0002229_neurodegeneration | 1.05990437 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 1.05847325 |
| 95 | MP0003633_abnormal_nervous_system | 1.05575626 |
| 96 | MP0004858_abnormal_nervous_system | 1.05020370 |
| 97 | MP0000751_myopathy | 1.04124915 |
| 98 | MP0001502_abnormal_circadian_rhythm | 1.01612989 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 1.00755111 |
| 100 | MP0008789_abnormal_olfactory_epithelium | 1.00411400 |
| 101 | MP0002277_abnormal_respiratory_mucosa | 1.00346609 |
| 102 | MP0000747_muscle_weakness | 0.99957576 |
| 103 | MP0001270_distended_abdomen | 0.99820434 |
| 104 | MP0004742_abnormal_vestibular_system | 0.98380465 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.98363586 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.97413242 |
| 107 | MP0003646_muscle_fatigue | 0.97248125 |
| 108 | MP0002160_abnormal_reproductive_system | 0.96620175 |
| 109 | MP0004130_abnormal_muscle_cell | 0.96614163 |
| 110 | MP0000685_abnormal_immune_system | 0.96566455 |
| 111 | MP0001944_abnormal_pancreas_morphology | 0.95860924 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.95768804 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.94953108 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.94740843 |
| 115 | MP0003631_nervous_system_phenotype | 0.91065213 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.90875772 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.89431761 |
| 118 | MP0009764_decreased_sensitivity_to | 0.88505694 |
| 119 | MP0004085_abnormal_heartbeat | 0.87658013 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85627238 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.85554717 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.85552224 |
| 123 | MP0003634_abnormal_glial_cell | 0.83871673 |
| 124 | MP0008874_decreased_physiological_sensi | 0.83699451 |
| 125 | MP0005671_abnormal_response_to | 0.83325345 |
| 126 | MP0001440_abnormal_grooming_behavior | 0.83311632 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.80697039 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.80499317 |
| 129 | MP0003632_abnormal_nervous_system | 0.80051079 |
| 130 | MP0002152_abnormal_brain_morphology | 0.79665453 |
| 131 | MP0000609_abnormal_liver_physiology | 0.79660403 |
| 132 | MP0001963_abnormal_hearing_physiology | 0.78747386 |
| 133 | MP0002752_abnormal_somatic_nervous | 0.77667480 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.75894679 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.75508057 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.74344251 |
| 137 | MP0001348_abnormal_lacrimal_gland | 0.74126501 |
| 138 | MP0004147_increased_porphyrin_level | 0.73774870 |
| 139 | MP0001529_abnormal_vocalization | 0.72555566 |
| 140 | MP0000534_abnormal_ureter_morphology | 0.72444302 |
| 141 | MP0003137_abnormal_impulse_conducting | 0.70922114 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.70354851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.02687595 |
| 2 | Hepatocellular necrosis (HP:0001404) | 4.22177380 |
| 3 | Hepatic necrosis (HP:0002605) | 4.09068394 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.03709098 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.00485070 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.87967846 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.86270368 |
| 8 | Acute encephalopathy (HP:0006846) | 3.67065151 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.64596571 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.55419173 |
| 11 | Ketosis (HP:0001946) | 3.46741206 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.42765085 |
| 13 | Focal motor seizures (HP:0011153) | 3.42652154 |
| 14 | Increased CSF lactate (HP:0002490) | 3.39825779 |
| 15 | Ketoacidosis (HP:0001993) | 3.29910297 |
| 16 | Pheochromocytoma (HP:0002666) | 3.27406219 |
| 17 | Hyperventilation (HP:0002883) | 3.26146877 |
| 18 | Myokymia (HP:0002411) | 3.23709627 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19321139 |
| 20 | Polyphagia (HP:0002591) | 3.17642153 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.16229403 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.16229403 |
| 23 | Ankle clonus (HP:0011448) | 3.09007756 |
| 24 | Spastic gait (HP:0002064) | 3.05433230 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.03557749 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.00109204 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93669170 |
| 28 | Pancreatic fibrosis (HP:0100732) | 2.93612671 |
| 29 | Reduced antithrombin III activity (HP:0001976) | 2.89965583 |
| 30 | Hypoglycemic coma (HP:0001325) | 2.87979235 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87192327 |
| 32 | Pancreatic cysts (HP:0001737) | 2.86423539 |
| 33 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.83786011 |
| 34 | Neuroendocrine neoplasm (HP:0100634) | 2.80705665 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 2.80684850 |
| 36 | Xanthomatosis (HP:0000991) | 2.78731870 |
| 37 | Death in childhood (HP:0003819) | 2.77552019 |
| 38 | Hypobetalipoproteinemia (HP:0003563) | 2.77340955 |
| 39 | Focal seizures (HP:0007359) | 2.74708843 |
| 40 | Lipid accumulation in hepatocytes (HP:0006561) | 2.70245516 |
| 41 | Visual hallucinations (HP:0002367) | 2.68528101 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.66413303 |
| 43 | Nephronophthisis (HP:0000090) | 2.63170692 |
| 44 | Lactic acidosis (HP:0003128) | 2.62054717 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.59150861 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.58877376 |
| 47 | Increased intramyocellular lipid droplets (HP:0012240) | 2.58419059 |
| 48 | Turricephaly (HP:0000262) | 2.57540341 |
| 49 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.56282726 |
| 50 | Hyperammonemia (HP:0001987) | 2.55997128 |
| 51 | Abnormal protein glycosylation (HP:0012346) | 2.53802838 |
| 52 | Abnormal glycosylation (HP:0012345) | 2.53802838 |
| 53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.53802838 |
| 54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.53802838 |
| 55 | Prolonged partial thromboplastin time (HP:0003645) | 2.52500321 |
| 56 | Clonus (HP:0002169) | 2.48746381 |
| 57 | Increased hepatocellular lipid droplets (HP:0006565) | 2.48112259 |
| 58 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48111381 |
| 59 | Opisthotonus (HP:0002179) | 2.46999763 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.44046049 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44046049 |
| 62 | Abnormality of midbrain morphology (HP:0002418) | 2.43263836 |
| 63 | Molar tooth sign on MRI (HP:0002419) | 2.43263836 |
| 64 | Anxiety (HP:0000739) | 2.43020648 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.41127241 |
| 66 | Cerebral hypomyelination (HP:0006808) | 2.40313221 |
| 67 | Action tremor (HP:0002345) | 2.39128868 |
| 68 | Optic disc pallor (HP:0000543) | 2.38074351 |
| 69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37537667 |
| 70 | Type I transferrin isoform profile (HP:0003642) | 2.37147183 |
| 71 | Gout (HP:0001997) | 2.35443532 |
| 72 | Cerebral edema (HP:0002181) | 2.33924423 |
| 73 | Abnormal social behavior (HP:0012433) | 2.33853822 |
| 74 | Impaired social interactions (HP:0000735) | 2.33853822 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.31636923 |
| 76 | Exercise intolerance (HP:0003546) | 2.31283252 |
| 77 | Impaired smooth pursuit (HP:0007772) | 2.30827768 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.30556411 |
| 79 | Increased serum lactate (HP:0002151) | 2.28281337 |
| 80 | Complement deficiency (HP:0004431) | 2.27547435 |
| 81 | Respiratory failure (HP:0002878) | 2.27206220 |
| 82 | Late onset (HP:0003584) | 2.27087303 |
| 83 | Renal cortical cysts (HP:0000803) | 2.26773499 |
| 84 | Gait imbalance (HP:0002141) | 2.26078947 |
| 85 | Lethargy (HP:0001254) | 2.22509425 |
| 86 | True hermaphroditism (HP:0010459) | 2.22347051 |
| 87 | Emotional lability (HP:0000712) | 2.22112984 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19656485 |
| 89 | Hypothermia (HP:0002045) | 2.18956949 |
| 90 | Supranuclear gaze palsy (HP:0000605) | 2.18615384 |
| 91 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.18409471 |
| 92 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.18409471 |
| 93 | Poor eye contact (HP:0000817) | 2.18159957 |
| 94 | Abnormal biliary tract physiology (HP:0012439) | 2.17559184 |
| 95 | Bile duct proliferation (HP:0001408) | 2.17559184 |
| 96 | CNS demyelination (HP:0007305) | 2.17047940 |
| 97 | Fair hair (HP:0002286) | 2.14442247 |
| 98 | Large for gestational age (HP:0001520) | 2.14327204 |
| 99 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.14090621 |
| 100 | Hyperbilirubinemia (HP:0002904) | 2.13394467 |
| 101 | Epileptiform EEG discharges (HP:0011182) | 2.13190252 |
| 102 | Epileptic encephalopathy (HP:0200134) | 2.12945304 |
| 103 | Neonatal onset (HP:0003623) | 2.12725205 |
| 104 | Intention tremor (HP:0002080) | 2.12462178 |
| 105 | Absent/shortened dynein arms (HP:0200106) | 2.12247759 |
| 106 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.12247759 |
| 107 | Cerebral inclusion bodies (HP:0100314) | 2.12116946 |
| 108 | Hyperglycinemia (HP:0002154) | 2.12065231 |
| 109 | Blue irides (HP:0000635) | 2.11865551 |
| 110 | Epidermoid cyst (HP:0200040) | 2.11851455 |
| 111 | Hypsarrhythmia (HP:0002521) | 2.11308902 |
| 112 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10809378 |
| 113 | Abnormality of the intrinsic pathway (HP:0010989) | 2.09143461 |
| 114 | Abnormality of the corticospinal tract (HP:0002492) | 2.08811329 |
| 115 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08266590 |
| 116 | Abnormality of the renal medulla (HP:0100957) | 2.07771486 |
| 117 | Progressive inability to walk (HP:0002505) | 2.07204872 |
| 118 | Congenital primary aphakia (HP:0007707) | 2.06007724 |
| 119 | Protruding tongue (HP:0010808) | 2.05832746 |
| 120 | Hyperglycinuria (HP:0003108) | 2.05651569 |
| 121 | Generalized hypopigmentation of hair (HP:0011358) | 2.02413016 |
| 122 | Hypolipoproteinemia (HP:0010981) | 2.02182793 |
| 123 | Progressive microcephaly (HP:0000253) | 2.01766659 |
| 124 | Occipital encephalocele (HP:0002085) | 2.01645425 |
| 125 | Dysmetria (HP:0001310) | 2.00858151 |
| 126 | Agitation (HP:0000713) | 2.00605052 |
| 127 | Type II lissencephaly (HP:0007260) | 2.00417008 |
| 128 | Inability to walk (HP:0002540) | 2.00297047 |
| 129 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99476715 |
| 130 | Chronic hepatic failure (HP:0100626) | 1.99258373 |
| 131 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98876576 |
| 132 | Hypoplasia of the brainstem (HP:0002365) | 1.98876576 |
| 133 | Abnormal gallbladder physiology (HP:0012438) | 1.98422840 |
| 134 | Cholecystitis (HP:0001082) | 1.98422840 |
| 135 | Poor suck (HP:0002033) | 1.97289456 |
| 136 | CNS hypomyelination (HP:0003429) | 1.96248159 |
| 137 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95881642 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.95881642 |
| 139 | Megalencephaly (HP:0001355) | 1.95226215 |
| 140 | Hemiparesis (HP:0001269) | 1.94266650 |
| 141 | Sclerocornea (HP:0000647) | 1.94063970 |
| 142 | Lower limb muscle weakness (HP:0007340) | 1.93203890 |
| 143 | Nonprogressive disorder (HP:0003680) | 1.92895963 |
| 144 | Generalized tonic-clonic seizures (HP:0002069) | 1.92802236 |
| 145 | Abnormal ciliary motility (HP:0012262) | 1.92579073 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.91363451 |
| 147 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91162744 |
| 148 | Cystic liver disease (HP:0006706) | 1.90871408 |
| 149 | Pachygyria (HP:0001302) | 1.90582376 |
| 150 | Status epilepticus (HP:0002133) | 1.89662757 |
| 151 | Progressive cerebellar ataxia (HP:0002073) | 1.89019142 |
| 152 | Focal dystonia (HP:0004373) | 1.87782744 |
| 153 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.87429190 |
| 154 | Polydipsia (HP:0001959) | 1.87172313 |
| 155 | Abnormal drinking behavior (HP:0030082) | 1.87172313 |
| 156 | Retinal dysplasia (HP:0007973) | 1.86716270 |
| 157 | Torticollis (HP:0000473) | 1.86638865 |
| 158 | Depression (HP:0000716) | 1.86107024 |
| 159 | Abnormality of the renal cortex (HP:0011035) | 1.86058949 |
| 160 | Restlessness (HP:0000711) | 1.85974378 |
| 161 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.85708533 |
| 162 | Thyroid-stimulating hormone excess (HP:0002925) | 1.85519892 |
| 163 | Abnormality of lateral ventricle (HP:0030047) | 1.85273061 |
| 164 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84756941 |
| 165 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84756941 |
| 166 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84756941 |
| 167 | Methylmalonic acidemia (HP:0002912) | 1.84669845 |
| 168 | Facial shape deformation (HP:0011334) | 1.84329001 |
| 169 | Potter facies (HP:0002009) | 1.84329001 |
| 170 | Atonic seizures (HP:0010819) | 1.83908444 |
| 171 | Generalized aminoaciduria (HP:0002909) | 1.83791879 |
| 172 | Hypoventilation (HP:0002791) | 1.83431086 |
| 173 | Cerebral hemorrhage (HP:0001342) | 1.83026320 |
| 174 | Symptomatic seizures (HP:0011145) | 1.81811399 |
| 175 | Leukodystrophy (HP:0002415) | 1.81537552 |
| 176 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.81238652 |
| 177 | Joint hemorrhage (HP:0005261) | 1.81154903 |
| 178 | Abnormal eating behavior (HP:0100738) | 1.80947985 |
| 179 | Craniofacial dystonia (HP:0012179) | 1.80698683 |
| 180 | Hypoalphalipoproteinemia (HP:0003233) | 1.80237697 |
| 181 | Severe muscular hypotonia (HP:0006829) | 1.79822675 |
| 182 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79821253 |
| 183 | Fetal akinesia sequence (HP:0001989) | 1.78807712 |
| 184 | Cerebral palsy (HP:0100021) | 1.78182917 |
| 185 | Amblyopia (HP:0000646) | 1.75977137 |
| 186 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73097748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K4 | 6.19467156 |
| 2 | MAP2K7 | 5.84233999 |
| 3 | MAP2K4 | 4.19023123 |
| 4 | TLK1 | 3.64675710 |
| 5 | MARK1 | 3.47799965 |
| 6 | MAPKAPK3 | 2.65494527 |
| 7 | MAP4K2 | 2.59113289 |
| 8 | STK16 | 2.56849329 |
| 9 | MARK3 | 2.36274742 |
| 10 | BMPR1B | 2.34998074 |
| 11 | DAPK2 | 2.22041664 |
| 12 | RET | 2.02122372 |
| 13 | ZAK | 1.89333798 |
| 14 | MAP3K11 | 1.79884537 |
| 15 | VRK2 | 1.72497914 |
| 16 | NTRK2 | 1.70183244 |
| 17 | CDK3 | 1.63547016 |
| 18 | VRK1 | 1.61885028 |
| 19 | PIM2 | 1.60174776 |
| 20 | SGK223 | 1.59323149 |
| 21 | SGK494 | 1.59323149 |
| 22 | TAOK3 | 1.58100276 |
| 23 | BCKDK | 1.57643429 |
| 24 | UHMK1 | 1.51611730 |
| 25 | CAMK1G | 1.45510204 |
| 26 | MINK1 | 1.43169848 |
| 27 | TNK2 | 1.41058994 |
| 28 | FGFR4 | 1.40726292 |
| 29 | NTRK3 | 1.38843957 |
| 30 | TAOK1 | 1.35557672 |
| 31 | ADRBK2 | 1.35471263 |
| 32 | FGFR2 | 1.34094407 |
| 33 | EEF2K | 1.33139851 |
| 34 | CAMKK2 | 1.31457984 |
| 35 | CSNK1G3 | 1.29186388 |
| 36 | CSNK1G2 | 1.28927972 |
| 37 | EPHA4 | 1.27736466 |
| 38 | TRIB3 | 1.26410242 |
| 39 | MAP4K1 | 1.26311718 |
| 40 | CASK | 1.25324339 |
| 41 | MARK2 | 1.23416744 |
| 42 | DYRK2 | 1.22093715 |
| 43 | SGK2 | 1.21678960 |
| 44 | PRPF4B | 1.16186110 |
| 45 | OXSR1 | 1.15852937 |
| 46 | NTRK1 | 1.15152279 |
| 47 | FRK | 1.14931070 |
| 48 | DAPK1 | 1.13974276 |
| 49 | CSNK1A1L | 1.12001403 |
| 50 | MAPK15 | 1.11205135 |
| 51 | FES | 1.10707969 |
| 52 | INSRR | 1.09067703 |
| 53 | PTK6 | 1.08808148 |
| 54 | CDK5 | 1.08717129 |
| 55 | SRPK1 | 1.04950235 |
| 56 | CAMKK1 | 1.01163083 |
| 57 | MAP3K7 | 0.99651359 |
| 58 | CSNK1G1 | 0.97454059 |
| 59 | MAPK13 | 0.95828598 |
| 60 | SGK3 | 0.95557109 |
| 61 | CAMK1D | 0.95097108 |
| 62 | HIPK2 | 0.94838686 |
| 63 | TESK1 | 0.94660220 |
| 64 | PAK6 | 0.92619415 |
| 65 | RPS6KA5 | 0.91926541 |
| 66 | OBSCN | 0.89822042 |
| 67 | PHKG1 | 0.89179799 |
| 68 | PHKG2 | 0.89179799 |
| 69 | CAMK2B | 0.88183873 |
| 70 | WNK3 | 0.87952194 |
| 71 | EPHB1 | 0.87722857 |
| 72 | TYRO3 | 0.84438737 |
| 73 | PINK1 | 0.82423278 |
| 74 | TXK | 0.81285210 |
| 75 | MAPKAPK5 | 0.80349724 |
| 76 | SIK2 | 0.80243612 |
| 77 | GRK1 | 0.79830906 |
| 78 | NME1 | 0.79746789 |
| 79 | MAP3K6 | 0.79549708 |
| 80 | SIK1 | 0.78895860 |
| 81 | MAPK12 | 0.78081104 |
| 82 | EPHA3 | 0.77805607 |
| 83 | CAMK2G | 0.77617118 |
| 84 | TESK2 | 0.77478261 |
| 85 | CDK19 | 0.77015138 |
| 86 | STK39 | 0.76638490 |
| 87 | CAMK2D | 0.76180957 |
| 88 | PRKCH | 0.73090195 |
| 89 | CSNK1A1 | 0.70522687 |
| 90 | GRK6 | 0.69419546 |
| 91 | ERBB4 | 0.64889964 |
| 92 | ICK | 0.62184044 |
| 93 | MAP3K2 | 0.62144128 |
| 94 | MUSK | 0.61750742 |
| 95 | LIMK1 | 0.61482922 |
| 96 | CAMK1 | 0.60544545 |
| 97 | KSR1 | 0.60535003 |
| 98 | PDGFRA | 0.60392723 |
| 99 | ERN1 | 0.60255688 |
| 100 | MAP3K9 | 0.58982183 |
| 101 | CAMK4 | 0.56986945 |
| 102 | MAP3K5 | 0.56864035 |
| 103 | PAK3 | 0.55844154 |
| 104 | PRKCG | 0.55594037 |
| 105 | MYLK | 0.54516773 |
| 106 | NUAK1 | 0.54468231 |
| 107 | PKN1 | 0.54269649 |
| 108 | IRAK2 | 0.54201153 |
| 109 | CDK8 | 0.53466520 |
| 110 | NME2 | 0.51703648 |
| 111 | YES1 | 0.51681287 |
| 112 | NEK2 | 0.49685271 |
| 113 | MAP2K6 | 0.49054018 |
| 114 | ABL2 | 0.48706173 |
| 115 | RPS6KA2 | 0.48628938 |
| 116 | PRKCQ | 0.48335822 |
| 117 | PRKD3 | 0.48198247 |
| 118 | PRKD2 | 0.48166466 |
| 119 | ROCK2 | 0.47905007 |
| 120 | PASK | 0.47582952 |
| 121 | IKBKB | 0.46496352 |
| 122 | ERBB2 | 0.46420114 |
| 123 | CDK15 | 0.45755660 |
| 124 | CAMK2A | 0.45602636 |
| 125 | CDK18 | 0.45406478 |
| 126 | ARAF | 0.45059987 |
| 127 | KSR2 | 0.44937678 |
| 128 | TGFBR1 | 0.43223313 |
| 129 | PRKCZ | 0.42761419 |
| 130 | AKT3 | 0.42293379 |
| 131 | DYRK1A | 0.42120366 |
| 132 | CDK14 | 0.41373773 |
| 133 | DYRK1B | 0.41000959 |
| 134 | SYK | 0.40473121 |
| 135 | WNK4 | 0.40428453 |
| 136 | MAP3K1 | 0.39509742 |
| 137 | MAP3K12 | 0.39418358 |
| 138 | PRKACA | 0.38954564 |
| 139 | BTK | 0.38504571 |
| 140 | PRKCE | 0.38433401 |
| 141 | PDK2 | 0.38340435 |
| 142 | GRK5 | 0.37512278 |
| 143 | CSF1R | 0.37443166 |
| 144 | PNCK | 0.36485138 |
| 145 | PRKAA1 | 0.35762541 |
| 146 | FLT3 | 0.35728976 |
| 147 | AKT2 | 0.34982435 |
| 148 | TRPM7 | 0.34905767 |
| 149 | PRKCI | 0.34887269 |
| 150 | CDK11A | 0.34838782 |
| 151 | CSNK1D | 0.34815059 |
| 152 | DAPK3 | 0.34791147 |
| 153 | BCR | 0.34698956 |
| 154 | STK38 | 0.34261816 |
| 155 | TBK1 | 0.33796049 |
| 156 | SCYL2 | 0.33353253 |
| 157 | ILK | 0.33286419 |
| 158 | CCNB1 | 0.32854020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.83857419 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.23729947 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.20270830 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18198305 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.12444096 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.50361185 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.50115674 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49227523 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.48866961 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.45936564 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.30767064 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30748000 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21069809 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.11720997 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.02019652 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.95958673 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.94863384 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.89080183 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.86132625 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85342089 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.81861964 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81091545 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.81000757 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.80332810 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.67727253 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63375730 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62590955 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53119879 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52058372 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50585767 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.48755394 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.46912679 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40263345 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.40087496 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38577008 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.37245772 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37095429 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.36363417 |
| 39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.36054740 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34788306 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34261922 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30868252 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.30636859 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 1.28335729 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.27810748 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.24498566 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.23714375 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22896561 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22544057 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.22293330 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21907698 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.18878153 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17465778 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16010990 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08635875 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07997996 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07503753 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.05096265 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02938045 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01959360 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 1.01919416 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01181407 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.99783234 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96567351 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96173745 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.95736812 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95127187 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95013261 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93925742 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.92501416 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92180336 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90817455 |
| 73 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.90340456 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90291219 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.86941940 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86089820 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85447569 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.84121434 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80254560 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78026238 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.76968796 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76495193 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74492474 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72875972 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72525134 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71988315 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71256017 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70923449 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70777875 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70562017 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70357784 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69697119 |
| 93 | Ribosome_Homo sapiens_hsa03010 | 0.68911110 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68195484 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.66524780 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66306963 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66201063 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65057336 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.63977715 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62686848 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62043997 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61892317 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.61620214 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.59018397 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.58709887 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58324977 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57579633 |
| 108 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56915889 |
| 109 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56181668 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.55731800 |
| 111 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55198410 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54778907 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54382170 |
| 114 | Axon guidance_Homo sapiens_hsa04360 | 0.54118199 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.53825274 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53358123 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.51364327 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50629853 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49903642 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.49705713 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49232748 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47082933 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45535935 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45296126 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43975291 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43964914 |
| 127 | Long-term depression_Homo sapiens_hsa04730 | 0.43553548 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43210063 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42378305 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42023983 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42013091 |
| 132 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41681297 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41267793 |
| 134 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40035177 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39467467 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39120904 |
| 137 | RNA degradation_Homo sapiens_hsa03018 | 0.38824383 |
| 138 | Gap junction_Homo sapiens_hsa04540 | 0.38498744 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38456889 |
| 140 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38455247 |
| 141 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37953965 |
| 142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37302628 |
| 143 | Alcoholism_Homo sapiens_hsa05034 | 0.36609618 |
| 144 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34693935 |
| 145 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34382659 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34153085 |

